Award type :
Product Development Award
Product Development Award
Product type :
Diagnostics
Diagnostics
Award year :
2020
2020
Project start date :
07 / 06 / 2020
07 / 06 / 2020
Project end date :
05 / 31 / 2021
05 / 31 / 2021
Project duration (months) :
12
12
Development stage :
Early Validation, Late Validation
Early Validation, Late Validation
Target disease :
COVID-19
COVID-19
Region served :
World
World
Recipient organization / Country of funding recipient organization :
Philmedi / Republic of Korea
Philmedi / Republic of Korea
Collaborator(s) / Country :
Mmonitor / Republic of Korea
Mmonitor / Republic of Korea
Funding amount(KRW) :
500,000,000
500,000,000
The R&D of an instrument-free, lateral flow molecular diagnostic platform for SARS-CoV-2 developed by Philmedi and Mmonitor. DNA manipulation is carried out on a single cartridge and quantified via smartphone. This project will aim to overcome the current limitations of traditional PCR methods; the platform could also be expanded to other diseases for the development of low-cost rapid diagnostic tests (RDTs).